<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03006406</url>
  </required_header>
  <id_info>
    <org_study_id>ENDO-1</org_study_id>
    <nct_id>NCT03006406</nct_id>
  </id_info>
  <brief_title>Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embryo Transfer in Patients With Endometriosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Zhengzhou University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gonadotropin-releasing hormone analogue (GnRH-a) is a synthetic decapeptide compound which
      can down-regulate pituitary function causing a temporary low estrogen state. Since
      endometriosis is an estrogen-dependent disease, the use of long-acting GnRH-a can control the
      growth of endometriosis by inhibiting ovary function.Some scholars have found that, for
      adenomyosis patients who received a super long protocol (pretreatment of long-acting GnRH-a
      for 1-2 months) in IVF treatment, the pregnancy outcome is comparable to that of the controls
      with normal uterus. Thus, the aim of this study is to compare the clinical pregnancy rate in
      patients treated with GnRH-a for 1, or 2 months.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical pregnancy rate</measure>
    <time_frame>5 weeks after embryo transfer</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of oocytes retrieved</measure>
    <time_frame>1 day at oocyte retrieved day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2 pronucleus(2PN)fertilization rate</measure>
    <time_frame>48hours after oocyte retrieved day</time_frame>
    <description>Number of 2PN/Matured oocytes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Clinical Pregnancy Rate</condition>
  <arm_group>
    <arm_group_label>Long term GnRH-a for 1 month</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patient in this group only receive GnRH-a 3.75 for 1 month</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patient in this group only receive GnRH-a 3.75 for 2 month</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient in this group only receive GnRH-a 3.75 for 2 month</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Long term GnRH-a (3.75mg)</intervention_name>
    <description>patient in this group only receive GnRH-a 3.75 for pituitary down-regulation</description>
    <arm_group_label>Long term GnRH-a for 1 month</arm_group_label>
    <arm_group_label>patient in this group only receive GnRH-a 3.75 for 2 month</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  first IVF cycle;

          -  with normal ovarian reserve(FSH(10miu/mlï¼› antral follicle count )3)

          -  with normal uterine

        Exclusion Criteria:

          -  Pre-implantation genetic diagnosis cycles;

          -  Oocyte donation cycles
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Huijuan Kong, M.D.</last_name>
    <phone>86-371-67966161</phone>
    <email>luckyjuanjuan819@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450052</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingpu Ms Sun, M.D,PhD</last_name>
      <phone>86-13803841888</phone>
      <email>syp2008@vip.sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Zhiqin Mr Bu, MD</last_name>
      <phone>86-15981978863</phone>
      <email>rmczzu@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>van der Houwen LE, Mijatovic V, Leemhuis E, Schats R, Heymans MW, Lambalk CB, Hompes PG. Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation. Reprod Biomed Online. 2014 Jan;28(1):39-46. doi: 10.1016/j.rbmo.2013.09.027. Epub 2013 Oct 9.</citation>
    <PMID>24262434</PMID>
  </reference>
  <reference>
    <citation>Mijatovic V, Florijn E, Halim N, Schats R, Hompes P. Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI. Eur J Obstet Gynecol Reprod Biol. 2010 Jul;151(1):62-5. doi: 10.1016/j.ejogrb.2010.02.047. Epub 2010 Apr 21.</citation>
    <PMID>20409633</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2016</study_first_submitted>
  <study_first_submitted_qc>December 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2016</study_first_posted>
  <last_update_submitted>December 29, 2016</last_update_submitted>
  <last_update_submitted_qc>December 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Zhengzhou University</investigator_affiliation>
    <investigator_full_name>Yingpu Sun</investigator_full_name>
    <investigator_title>Director of Reproductive Medical Center,1st Affilated Hospital, Zhengzhou University</investigator_title>
  </responsible_party>
  <keyword>endometriosis</keyword>
  <keyword>long term GnRH-a</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

